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Background: The PI3K/Akt pathway is activated upon oxidative stress.
Results: The PI3K/Akt pathway partially protects the neuron against cellular oxidant generation via FoxO3a phosphorylation.
Conclusion: The PI3K/Akt pathway plays a pleiotropic protective role under oxidative stress.
Significance: This pathway could be used as a therapeutic target in oxidative stress-related disorders.
The PI3K/Akt pathway is a key component in synaptic plas-
ticity and neuronal survival. The aim of this work was to inves-
tigate the participation of the PI3K/Akt pathway and its out-
come on different molecular targets such as glycogen synthase
kinase 3 (GSK3) and Forkhead box-O (FoxO) transcription
factors during mild oxidative stress triggered by iron overload.
The exposure of mouse hippocampal neurons (HT22) to differ-
ent concentrations of Fe2 (25–200M) for 24 h led us to define
a mild oxidative injury status (50 M Fe2) in which cell mor-
phology showed changes typical of neuronal damage with
increased lipid peroxidation and cellular oxidant levels but no
alteration of cellular viability. There was a simultaneous
increase in both Akt and GSK3 phosphorylation. Levels of
phospho-FoxO3a (inactive form) increased in the cytosolic frac-
tion of cells treated with iron in a PI3K-dependent manner.
Moreover, PI3K andAkt translocated to the nucleus in response
to oxidative stress. Iron-overloaded cells harboring a constitu-
tively active form of Akt showed decreased oxidants levels.
Indeed, GSH synthesis under oxidative stress conditions was
regulated by activated Akt. Our results show that activation of
the PI3K/Akt pathway during iron-induced neurotoxicity regu-
lates multiple targets such as GSK3, FoxO transcriptional
activity, and glutathione metabolism, thus modulating the neu-
ronal response to oxidative stress.
Iron-induced oxidative stress is a hallmark of neurodegen-
erative disorders such asAlzheimer’s disease (AD)2 and Parkin-
son’s disease (1, 2). This redox milieu in which neurons are
immersed becomes extremely hostile, enhancing neurodegen-
eration processes and triggeringmultiple and opposing cellular
responses. The precise molecular targets providing neuronal
resistance to oxidative stress and the manner in which neurons
determine their final fate of survival or death are still to be
elucidated.
In this connection, the serine-threonine kinase Akt has been
studied extensively because of its participation in cellular out-
come. Akt is the main downstream effector of PI3K (3, 4). Its
activation is initiated bymembrane recruitment via interaction
of its pleckstrin homology domain with phosphatidylinositol
3,4,5-trisphosphate synthesized by PI3K from phosphatidyli-
nositol 4,5-bisphosphate. After membrane anchoring, Akt is
phosphorylated sequentially by phosphoinositide-dependent
kinase 1 (PDK-1) at threonine 308 andby themammalian target
of rapamycin complex 2 (mTORC2) at serine 473 (5). Upon
phosphorylation, Akt translocates from the plasma membrane
to intracellular compartments, including the cytoplasm and
nucleus, where it phosphorylates a variety of substrates (6).One
of these substrates is glycogen synthase kinase 3 (GSK3),
which is inhibited through phosphorylation at serine 9 by Akt
(3). GSK3 activity is involved in neuronal cell death, and
cumulative evidence demonstrates the role of GSK3 inhibi-
tors in neuroprotection (7). In vivo models overexpressing
GSK3 in the brain show signs of neurodegeneration and spa-
tial learning deficits (8). In addition, the decrease in Akt activity
and the increase in GSK3 activity have been described in cells
from familial AD patients that contain mutated presenilin1/2
(9).
Another target lying downstream of PI3K/Akt signaling is
the class O of forkhead box (FoxO) transcription factors. The
FoxO family binds to the Forkhead response element and
increases the expression of proapoptotic genes (10). The tran-
scriptional activity of FoxO is dependent on the phosphoryla-
tion of three key residues (threonine 24, serine 256, and serine
319) by Akt. The phosphorylation state of FoxO governs its
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subcellular localization (11). Although the triple-phosphory-
lated form is exported from the nucleus and retained in the
cytoplasm in aCrm-1- and 14-3-3-dependentmanner, the non-
phosphorylated form resides in the nucleus and is capable of
transcribing target apoptotic genes (12). Thus, FoxO transcrip-
tional activity is essential in programmed cell death during
development but has also been implicated in the initiation of
apoptosis during neuronal injury, as in the case of neurodegen-
erative disorders in the mature nervous system (13, 14).
One opposite and unexpected role for Akt has been de-
scribed by Nogueira et al. (15). They demonstrated that
strongly activated Akt increases oxidative stress levels and
makes the cell more susceptible to oxidative injury. This
increase in pro-oxidant conditions could be caused by the Akt-
dependent up-regulation of oxidative phosphorylation and
oxygen consumption. In addition, hyperactivated Akt could
lead to a sustained inhibition of FoxO transcription factors,
particularly FoxO3a, which normally up-regulates the expres-
sion of antioxidant proteins such as superoxide dismutase
(SOD) 2, catalase, and sestrins (16, 17). These intriguing find-
ings relating to the ability of Akt to increase reactive oxygen
species through the down-regulation of antioxidant defenses
could be a double-edged sword and appear to be strictly related
to the extent and time-lapse of Akt activation. In cancer cells,
this ability could be exploited by using oxidant therapies, but in
neurons it could lead to lethal damage under brain oxidative
conditions, as it is the scenario of AD and Parkinson’s disease.
Thus, the mechanism of Akt participation in neuronal oxida-
tive injury remains puzzling and largely unclear.
In previous work from our laboratory, we demonstrated that
iron-induced oxidative damage activates the PI3K/Akt pathway
in synaptic terminals, GSK3 being one of the main down-
stream effectors (18, 19). We also demonstrated that synaptic
Akt and ERK 1/2 signaling were differentially activated by the
presence of amyloid  peptide (A) and iron overload (20).
However, the role of synaptic Akt activation in neuronal fate
can only be fully understood if it is studied in the whole neuron.
In view of the above, the aim of this study has been to describe
the role of PI3K/Akt activation during iron-induced oxidative
injury in hippocampal neurons. Our attention has been focused
mainly on two main targets of PI3K/Akt-FoxO3a and GSK3,
their involvement in the response to oxidative injury and, ulti-
mately, the determination of neuronal fate.
EXPERIMENTAL PROCEDURES
Cell Culture, Chemicals, and Treatments—HT22 cells, a sta-
ble murine hippocampal cell line, were used for the experi-
ments. Cells were maintained in DMEM supplemented with
10% FBS (Natocor, Argentina), 100 units/ml penicillin, 100
g/ml streptomycin, and 0.25 g/ml amphotericin B at 37 °C
under 5% CO2. For all experiments, cells were grown to
80–90% confluence. Transfection was carried out with Lipo-
fectamine 2000 (Invitrogen). Ferrous sulfate (J. T. Baker, cata-
log no. 2070-01) was purchased in EMD Millipore (Millipore,
Bedford, MA). Inhibitor IV (catalog no. sc-203809) was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA). 2,7-
Dichlorofluorescein diacetate (DCDCDHF, catalog no.D6883),
2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydro-
chloride (LY294002, catalog no. L9908), lithium chloride (cat-
alog no. L9650), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide (MTT, catalog no. M2128), and DAPI (cata-
log no. D9542) were purchased from Sigma Aldrich (St. Louis,
MO). Fe2 treatments were carried out in serum-free medium.
Treatments with LY294002, lithium (Li), and inhibitor IV
were performed as follows.Mediumwas removed and replaced
by serum-free medium. Inhibitors were then added to the
desired final concentration (controls received vehicle alone).
After 30 min, Fe2 was added, and cells were incubated under
these conditions for 24 h.
Antibodies—Antibodies against catalase (catalog no.
sc-34285), SOD1 (catalog no. sc-11407), SOD2 (catalog no.
sc-30080), -actin (catalog no. sc-47778), -GCSc (catalog
no. sc-22755), and human NAP-related protein (catalog no.
sc-32301) were purchased from Santa Cruz Biotechnology.
Antibodies against phospho-Ser-473-Akt (catalog no. cs9271),
Akt (catalog no. cs9272), phospho-Ser-9-GSK3 (catalog no.
cs9336), GSK3 (catalog no. cs9332), PTEN (catalog no.
cs9556), phospho-Ser-253-FoxO3a (catalog no. cs9466),
FoxO3a (catalog no. cs2497), and sirtuin 3 (catalog no. cs2627)
were purchased fromCell Signaling Technology (Beverly,MA).
Antibody againstMAPK/ERKkinase (catalog no. SAB4502404)
was purchased from Sigma Aldrich. Antibody against PI3K
(catalog no. 06-497) was purchased from Upstate/Millipore
(Temecula, CA). Antibody against HA was purchased from
BAbCo (Richmond, CA). Cy-2-conjugated secondary antibod-
ies were from Jackson ImmunoResearch (West Grove, PA).
Plasmids—Expression plasmids, including pCMV6-Myr-
Akt-HA (Myr-Akt), pECE-HA-FoxO3a WT (FoxO3a-WT),
and pECE-HA-FoxO3a TM (FoxO3a-TM), were gifts from Dr.
Alex Toker (Beth Israel Deaconess Medical Center, Harvard
Medical School).
Assessment of Cell Viability—Cell viability was assessed by
MTT reduction assay. MTT is a water-soluble tetrazolium salt
that is reduced by metabolically viable cells to a colored, water-
insoluble formazan salt. After treatments, MTT (5 mg/ml) was
added to the cell culture medium at a final concentration of 0.5
mg/ml. After incubating the plates for 2 h at 37 °C in a 5% CO2
atmosphere, the assay was stopped, and the MTT-containing
medium was replaced with solubilization buffer (20% SDS (pH
4.7)). The extent of MTT reduction was measured spectropho-
tometrically at 570 nm. Results are expressed as a percentage of
the control.
Determination of Lipid Peroxidation—Lipid peroxidation
was determined by thiobarbituric acid reactive substances
(TBARS) assay, which involves derivatization of malondialde-
hyde with thiobarbituric acid to produce a pink product that is
quantified in a UV-visible spectrophotometer. Briefly, after
treatments, cells were scraped off into 200 l of ice-cold water
andmixed with 0.5 ml of 30% TCA. Then, 50l of 5 NHCl and
0.5 ml of 0.75% thiobarbituric acid were added. Tubes were
capped, the mixtures were heated at 100 °C for 15 min in a
boiling water bath, and the samples were centrifuged at 1000
g for 10 min. TBARS were measured spectrophotometrically in
the supernatant at 535 nm. Results are expressed as a percent-
age of the control.
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Determination of Cell Oxidant Levels—Cell oxidative stress
was evaluated using DCDCDHF. This probe can cross the
membrane, and, after oxidation, it is converted into a fluores-
cent compound. After the corresponding treatments, the
medium was discarded, and complex medium containing 10
M DCDCDHF (Molecular Probes, Eugene, OR) was added.
After 30 min of incubation at 37 °C, the medium was removed,
and cells were rinsed three times with PBS and then either
imaged with an epifluorescence microscope or lysed in a buffer
containing PBS and 1% Nonidet P-40. Fluorescence in the
lysates (ex 538, em 590) was measured in an SLMmodel
4800 fluorimeter (SLM Instruments, Urbana, IL). Results are
expressed as arbitrary units.
Cytoplasmic and Nuclear fractionation with Nonidet P-40
Detergent-containing Buffer—Nuclear and cytosolic fractions
were isolated as described previously (21, 22). After treatments,
the medium was discarded, and cells were rinsed with PBS and
scraped. After centrifugation at 800  g for 10 min, the pellet
(10 106 cells) was resuspended in 100 l of buffer A (10 mM
HEPES (pH 7.9), 1.5 mMMgCl2, 10 mMKCl, 0.5 mMDTT, 0.1%
Nonidet P-40, 2 g/l leupeptin, 1 g/l aprotinin, 1 g/l
pepstatin), incubated for 10 min at 4°C, and centrifuged for 2
min at 12,000  g. The supernatant (cytosolic fraction) was
removed, and the nuclear pellet was resuspended in 40 l of
buffer B (10mMHEPES (pH 7.9), 1.5 mMMgCl2, 420mMNaCl,
0.5 mM DTT, 0.2 mM EDTA, 25% glycerol, 0.5 mM PMSF, 2
g/ml leupeptin, 1 g/ml aprotinin, 1 g/ml pepstatin). Sam-
ples were incubated for 20 min at 4°C and centrifuged at
10,000 g for 15 min at 4°C. Protein concentration was deter-
mined by themethod of Bradford (23), and samples were stored
at20°C until used for Western blot analyses.
Western Blot Analysis—For the preparation of total cell
extracts, cells (10 106 cells)were rinsedwithPBS, scraped and
centrifuged. The pellet was rinsedwith PBS and resuspended in
200l of a buffer containing 50mMTris (pH7.5), 150mMNaCl,
0.1%TritonX-100, 1%Nonidet P-40, 2mMEDTA, 2mMEGTA,
50 mM NaF, 2 mM -glycerophosphate, 1 mM Na3VO4, 10
g/ml leupeptin, 5 g/ml aprotinin, 1 g/ml pepstatin, 0.5 mM
PMSF, and 0.5 mM DTT. Samples were exposed to one cycle of
freezing and thawing, incubated at 4 °C for 30 min, and centri-
fuged at 15,000 g for 30 min. The supernatant was decanted,
and the protein concentration was measured (23). Aliquots of
total, nuclear, or cytosolic fractions containing 25–50 g of
protein were separated by reducing 7–12.5% polyacrylamide
gel electrophoresis and electroblotted to polyvinylidene difluo-
ride membranes (Millipore). Molecular weight standards
(SpectraTM multicolor broad-range protein ladder, Thermo
Scientific) were run simultaneously. Membranes were blocked
with 5% nonfat dry milk in TBS-T buffer (20 mM Tris-HCl (pH
7.4), 100 mM NaCl, and 0.1% (w/v) Tween 20) for 2 h at room
temperature and then incubated with primary antibodies
(anti-phospho-Ser-473-Akt, anti-Akt, anti--GCSc, anti-phos-
pho-Ser-9-GSK3, anti-GSK3, anti-PTEN, anti-phospho-
Ser-253-FoxO3a, anti-FoxO3a, anti-phospho-Ser-256-FoxO1,
anti- MAPK/ERK kinase, anti-PI3K, anti-catalase, anti-SOD1,
anti-SOD2, anti- actin, and anti- human NAP-related protein
(1:1000) overnight at 4 °C),washed three timeswithTBS-T, and
then exposed to the appropriate HRP-conjugated secondary
antibody for 1 h at room temperature. Membranes were again
washed three times with TBS-T, and immunoreactive bands
were detected by ECL (GE Healthcare) using standard x-ray
film (Kodak X-OMAT AR, GE Healthcare). Immunoreactive
bands were quantified using image analysis software (ImageJ, a
freely available application in the public domain for image anal-
ysis and processing developed and maintained by Wayne Ras-
band at the Research Services Branch, National Institute of
Mental Health).
Determination of GSH Levels—GSH content from total cell
extracts was determined by using a spectrophotometric assay
method that involves oxidation of GSH by the sulfhydryl rea-
gent 5,5-dithio-bis(2-nitrobenzoic acid) to form the yellow
derivative 5-thio-2-nitrobenzoic acid, measurable at 412 nm.
Immunofluorescence Microscopy—HT22 cells were grown
onto glass coverslips, and the growingmediumwas replaced by
serum-free medium. After treatment with 50 M Fe2 for 24 h,
the cells were fixed with precooled methanol for 10 min at
20 °C, followed by two washes in PBS. For the immuno-
staining, the nonspecific sites were blockedwith 5%BSA in PBS
at room temperature for 30 min. Cells were incubated with the
appropriate primary antibody (1:50 in PBS, 2%BSA, 1 h at room
temperature). After three washes with PBS, cells were incu-
bated with Cy-2-conjugated secondary antibody (1:200, 1 h,
room temperature) and DAPI or TO-PRO for nuclear staining.
After washing with PBS at room temperature for 10 min, cov-
erslips were mounted, and slides were viewed with a Nikon
EclipseTi-S fluorescencemicroscope or a LeicaTCSSP2AOBS
confocal laser microscope.
Statistical Analysis—Quantitative results were expressed as
themeans S.E. ofmeasurement and analyzed byMTT reduc-
tion, TBARS assay, cell oxidant levels, Akt, and GSK3 phos-
phorylation. PI3K, Akt, GSK3, and PTEN subcellular redistri-
bution were analyzed by ANOVA to determine group
differences, followed by Tukey’s post hoc analysis to determine
specific differences between conditions. Cell oxidant levels in
overexpression experiments were analyzed with two-way,
repeated-measures ANOVA to determine the main effects of
protein overexpression and treatments, followed by Tukey’s
post hoc comparisons to determine differences between Fe2
and the control condition and also differences between the
overexpressed proteins. Cell oxidant levels in Fig. 1D and cata-
lase, SOD1, and SOD2 expression were analyzed by Student’s t
test. Statistical significance for all analyses was accepted at p
0.05. The Western blots shown are representative of at least
three analyses performed on samples from at least three sepa-
rate experiments.
RESULTS
Cellular Effects of Fe2-induced Oxidative Stress—We have
previously characterized an iron-induced oxidative stress
model in cerebral cortex synaptic endings (18, 19).Wehave also
described the activation of the PI3K/Akt pathway in synaptic
endings exposed to iron-induced oxidative injury (19). In this
report, we havemoved to a neuronalmodel to completely char-
acterize the role of PI3K/Akt activation during neuronal iron-
induced oxidative stress. For this purpose,murine hippocampal
neurons, HT22 cells, were exposed to increasing Fe2 concen-
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trations (25, 50, 100, and 200 M) for 24 h. Control conditions
were also assessed, replacing Fe2 with an equal volume of
water (vehicle). To determine the extent of neuronal injury, cell
morphology and viability and lipid peroxidation levels were
evaluated. As shown in Fig. 1A, exposure to the metal ion
caused evident morphological alterations typical of neuronal
damage (cytoplasmic retraction, rounding of the cell bodies,
and diminution in the number of neuronal projections) that
were found to be iron concentration-dependent. Cell viability,
assessed by MTT reduction assay, was found to be diminished
significantly only in the presence of the two highest concentra-
tions of iron assayed (50 and 62% lower than the control condi-
tion for 100 and 200 M, respectively, Fig. 1B) where neuronal
morphology was extremely altered. Lipid peroxidation levels,
evaluated by TBARS assay, were found to be increased signifi-
cantly by iron concentrations of 50 M or higher (107%, 189%,
and 349% higher than the control for 50, 100, and 200 M,
respectively, Fig. 1C). Because 50 M Fe2 was found to be the
lowest concentration of themetal ion capable of causing notice-
able morphological changes, with a slight but significant
increase in lipid peroxidation but no significant mitochondrial
dysfunction and death, we next assessed the levels of cellular
oxidants generated by the exposure to this concentration of
iron. A very significant increase in cellular reactive oxygen spe-
cies (measured by using the probe DCDCDHF) was observed
after treatment with 50 M Fe2 both by fluorescence micros-
copy and spectrofluorometry (Fig. 1, D and E). Moreover, syn-
aptophysin, an integral membrane protein of synaptic vesicles
whose distribution and abundance make it a useful synaptic
marker, was observed to be decreased significantly after the
exposure to 50 M Fe2 (Fig. 1F). These results allow us to
define a model of mild oxidative stress-triggered neurodegen-
eration generated by the exposure of hippocampal HT22 neu-
rons to 50 M Fe2, characterized by noticeable morphological
changes, increased production of cellular oxidants, and, thus,
lipid peroxidation and a significant loss of synaptic endings, but
without clear signs of neuronal death.
State of Akt and GSK3 Phosphorylation upon Fe2-induced
Oxidative Stress—After characterizing our model, we next
investigated the participation of the PI3K/Akt/GSK3 pathway
in cellular signaling events triggered by iron-induced mild oxi-
dative stress. Akt andGSK3 phosphorylation levels were eval-
uated byWestern blot analysis and normalized to total Akt and
GSK3 levels, respectively. Consistent with our previous
results in isolated synaptic endings (18, 19), the presence of iron
(25 and 50M) caused an increase in the phosphorylation levels
of bothAkt (737 and 648%with respect to the control for 25 and
50 M Fe2, respectively) and GSK3 (100 and 335% with
respect to the control for 25 and 50 M Fe2, respectively, Fig.
2A) inHT22 neurons.Of note, Akt is activatedwhen phosphor-
ylated in serine 473, whereas GSK3 is inhibited when phos-
phorylated in serine 9. The well documented PI3K inhibitor
LY294002 (10 M) strongly decreased Akt phosphorylation in
the presence of iron. These results support the PI3K depend-
ence of Akt activation under oxidative stress conditions in hip-
pocampal neurons (Fig. 2B). Because these data support our
FIGURE 1. Characterization of the oxidative stress status in HT22 cells after treatments. A, photomicrographs of the cells exposed to Fe2 (0–200M). B,
MTT reduction assay. Cells were treated with Fe2 (0–200 M) or its vehicle for 24 h, and cell viability was assessed as described under “Experimental
Procedures.” Results are expressed as a percentage of the control and represent mean S.E. (n 3–5). ***, p 0.001 for each condition with respect to the
control; one-way ANOVA and Tukey’s post hoc test. C, TBARS assay. Cells were exposed to Fe2 (0–200 M) or its vehicle for 24 h, and lipid peroxidation was
studied as described under “Experimental Procedures.” Results are expressed as a percentage of the control and represent mean S.E. (n 3–4). *, p 0.05;
**, p 0.01; ***, p 0.001 for each conditionwith respect to the control; one-way ANOVA and Tukey’s post hoc test.D and E, determination of cellular oxidant
levels. Cells were treated with 50 M Fe2 for 24 h and then incubated in the presence of 10 M DCDCDHF as described under “Experimental Procedures.”
Cellular oxidant levels were quantified by spectrofluorometry (D) and imaged with an epifluorescence microscope (E, 1 and 2). 3 and 4 in E are differential
interference contrast images of 1 and 2, respectively. The results inD are expressed as arbitrary units and represent themean S.E. (n 3). ***, p 0.001with
respect to the control; Student’s t test. The micrographs shown in E are representative of at least three analyses performed on samples from at least three
separate experiments. F, synaptic marker expression. After the exposure to Fe2 50 M, cell lysates were prepared for Western blot studies. Synaptophysin
expression is shown in a representative blot of three different studies.
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notion that this pathway, found previously to be activated
locally in the synaptic terminals, is activated in the whole neu-
ron, we hypothesize that the PI3K/Akt pathway plays a key role
in the neuronal response to oxidative stress, participating either
in pathogenic or protective mechanisms.
Role of PI3K/Akt/GSK3 in Iron-induced Cellular Oxidant
Generation—To test our hypothesis that PI3K/Akt/GSK3
pathway is involved in some way in the generation of reactive
oxygen species (ROS), cells were incubated with either 10 M
LY294002 or its vehicle for 30 min prior to the exposure to 50
M Fe2 (and then all along the treatment with this metal), and
cellular oxidant levels were evaluated by fluorescence micros-
copy using the probe DCDCDHF. As shown in Fig. 3A, 2, ROS
content increased after exposure to 50 M Fe2. When cells
were coincubated with LY294002, the increase in cellular oxi-
dants was greater than that observed in the presence of iron
alone (Fig. 3A, 3). These results suggest that PI3K plays a pro-
tective role against oxidative stress, hindering the production of
cellular oxidants.
To reinforce these results, cells were incubatedwith either 10
M LY294002, 5 mM Li (GSK3 inhibitor), 10 M of inhibitor
IV (Akt inhibitor), or the corresponding vehicles for 30 min prior
to the exposure to 50 M Fe2 (and then all along the treatment
with the latter), and cellular oxidant levelsweremeasuredby spec-
trofluorometry using DCDCDHF (Fig. 3B). The coincubation of
iron and LY294002 (PI3K inhibition) caused a significant increase
in ROS levels compared with incubation in the presence of iron
alone. The same result was found with the coincubation of iron
and inhibitor IV (Akt inhibition). No changes were observed after
the coincubation of iron and Li (GSK3 inhibition, whichmim-
ics the outcome of Akt activation).
To further address the role of Akt in the process of ROS
generation during iron-induced oxidative stress, HT22 cells
were transfected with either a constitutively active mutant of
Akt (Myr-Akt) or the empty vector before the treatments with
Fe2 or its vehicle. As seen in Fig. 3C, overexpression of consti-
tutively active Akt abolished Fe2-induced ROS generation.
Taken together, these data allow us to conclude that both PI3K
and its downstream effector Akt play crucial roles in preventing
the increase of cellular oxidants in a model of mild oxidative
insult.However,GSK3 either does not participate inROSgen-
eration or has already been inhibited by Fe2 and is not further
inhibited by Li.
PI3K/Akt/GSK3 Intracellular Trafficking upon Oxidative
Stress—Because Akt was shown to be phosphorylated (acti-
vated) after iron treatment, we sought to determine whether
FIGURE 2.Western blot analyses of the PI3K/Akt pathway. A, cells were exposed to Fe2 (25 and 50M) for 24 h. Cell lysates were prepared forWestern blot
analysis as described under “Experimental Procedures,” and Akt and GSK3 phosphorylation was assessed. TheWestern blot in each case is representative of
three different experiments. Bands of proteins were quantified using scanning densitometry. The data in the graphs in the right panel represent the ratio
between the phosphorylated state and the total level of each protein, expressed as a percentage of the corresponding control condition (mean S.E. of three
different experiments). ***, p 0.001 for each conditionwith respect to the control; one-wayANOVA and Tukey’s post hoc test. B, cells were incubatedwith 10
M LY294002 or its vehicle for 30 min before exposure to Fe2 and all along the treatment (24 h). Cell lysates were prepared for Western blot analysis as
described under “Experimental Procedures,” and Akt phosphorylationwas assessed. TheWestern blot shown is representative of three different experiments.
Proteins were quantified as indicated in A. The results are expressed as a percentage of the control (mean S.E. of three different experiments). ***, p 0.001
with respect to the control; ###, p 0.001 shown in the picture; one-way ANOVA and Tukey’s post hoc test.
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iron-induced PI3K/Akt activation involved a differential cellu-
lar compartmentalization or redistribution of its components.
For this purpose, cells were treated with 50 M Fe2 for 24 h
and then PI3K, Akt, GSK3, and phosphatase and PTEN local-
ization was assessed by immunocytochemistry (Fig. 4, A–D).
Fluorescence microscopy studies show clearly that both PI3K
and Akt increased their nuclear localization after treatment
with the metal ion compared with the control condition (Fig. 4,
A and B). However, GSK3 showed the opposite pattern. It
decreased its nuclear localization in the presence of Fe2 (Fig.
4C). PTEN was mainly located in the nucleus both in control
and treated cells and did not show any significant change in
response to iron treatment (Fig. 4D).
To further substantiate the results observed by immunocy-
tochemistry, Fe2-treated cells were collected, and the nuclear
and cytosolic fractions were isolated and analyzed by Western
blot analysis. Human NAP-related protein and MAPK/ERK
kinasewere used as nuclear and cytosolicmarkers, respectively,
and -actin was used as a loading control. Both PI3K and Akt
translocated to the nucleus after Fe2-triggered oxidative
stress. GSK3 translocated from the nucleus to the cytosol, and
PTEN showed no significant change (Fig. 4E). Together, these
findings show that both PI3K and Akt undergo intracellular
trafficking toward the nuclear compartment and that GSK3 is
redirected in the opposite direction in response to iron-induced
oxidative stress.
Consequences of Fe2-induced Oxidative Stress on FoxO3a
Transcription Factor—Because PI3K/Akt translocated to the
nucleus in response to oxidative stress and FoxO transcription
factors are well known molecular targets of PI3K/Akt, we next
investigated whether this pathway exerts any effects on
FoxO3a. Subcellular fractionation followed by Western blot
studies showed that phosphorylated Foxo3a (the transcription-
ally inactive form) strongly increased in the cytosolic fraction
(and, to amuch lesser degree, in the nuclear fraction) upon iron
exposure, whereas total FoxO3a (both active and inactive
forms) decreased in the nuclear fraction (Fig. 5A). In agreement
with these results, immunocytochemistry experiments showed
that, in the absence of iron, FoxO3a is mainly located in the
nucleus but that, upon iron-induced oxidative stress, it is local-
ized more in the cytosol although still present in the nucleus
(Fig. 5D).
FIGURE 3. Cellular oxidant production. A, HT22 cells were incubatedwith 10M LY294002 or its vehicle for 30min before exposure to Fe2 and all along the
treatment (24 h). They were subsequently incubated with 10 M DCDCDHF for 30 min and imaged with an epifluorescence microscope (1, 2, and 3). 4, 5, and
6 showdifferential interference contrast images of 1, 2, and 3, respectively. B, HT22 cells were treatedwith either 10M LY294002, 5mM Li, 10M inhibitor IV,
or their vehicles for 30 min before the addition of 50 M Fe2. Cellular oxidant levels were quantified by spectrofluorometry. The results are expressed as
arbitrary units and representmean S.E. (n 3–5). ***, p 0.001 for each conditionwith respect to the control; ###, p 0.001 shown in the picture; one-way
ANOVA and Tukey’s post hoc test. C, cells were transfected with either HA-Myr-Akt or the empty vector and subsequently exposed to 50 M Fe2. Cellular
oxidant levelswerequantified asdescribedpreviously. Results are expressedas arbitrary units and represent themeanS.E. (n3). ***,p0.001with respect
to the control; ###, p 0.001 shown in the picture; one-way ANOVA and Tukey’s post hoc test. D, cells were transfected with HA-Myr-Akt and processed for
immunocytochemistry using antibodies against HA (left panel) to show transfection efficiency. DAPI was used as nuclear marker (right panel).
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To correlate the increase in FoxO3a phosphorylation with
PI3K/Akt activation, we carried out the same experiments in
the presence of 10 M LY294002. As shown in Fig. 5B, PI3K
inhibition clearly abolished the increased phosphorylation of
FoxO3a induced by Fe2 in both the cytosolic and the nuclear
fraction. Although it is generally accepted that Akt activation is
a PI3K-dependent event, we also checked whether nuclear
translocation of Akt was dependent on PI3K in our experimen-
tal model. Fig. 5C shows that incubation with LY294002 abol-
ished the oxidative stress-induced translocation of Akt to the
nucleus.
Because the antioxidant enzymes SOD1, SOD2, and catalase
are well known target genes of FOXO3a transcriptional activity
(24), their expression was assessed by Western blot analysis.
Catalase showed no changes after the exposure to 50 M Fe2
with respect to the control, whereas SOD1 and SOD2 were
found to be decreased under the same conditions (Fig. 5E).
Given that sirtuins (SirT) have been reported to participate in
the regulation of FoxO transcription factors by acetylation, we
investigated SirT3 subcellular distribution upon oxidative
stress exposure. Western blot studies of cytosolic and nuclear
fractions revealed that SirtT3 is localized mainly in the nucleus
under the control condition and is exported out of the nucleus
after iron treatment (Fig. 5F). Taken together, these results
allow us to conclude that PI3K and Akt translocate to the
nucleus in response to oxidative stress and that, consequently,
FIGURE 4. Subcellular localization of the PI3K/Akt pathway. (A-D) HT22 cells were grown onto coverslips, exposed to either 50 M Fe2 or its vehicle, and
processed for immunocytochemistry using antibodies against PI3K (A), Akt (B), GSK3 (C), and PTEN (D). DAPI was used as nuclear marker in all the pictures
(A–D). One representative picture from three different experiments is shown. E, subcellular fractions obtained from cells exposed to 50M Fe2 (as described
under “Experimental Procedures”) were analyzed byWestern blot analysis using antibodies against PI3K, Akt, GSK3, and PTEN.MAPK/ERK kinasewas used as
cytosolic marker and human NAP-related protein as a nuclear marker. -actin was used as a loading control. The blot in each case is representative of at least
three different experiments. Bands of proteins were quantified using scanning densitometry. The data in the graph in the right panel represent the ratio
between subcellular protein expression and -actin, expressed as a percentage of the corresponding control condition (mean  S.E. of three different
experiments). *, p 0.05; ***, p 0.001 for each condition with respect to the control; one-way ANOVA and Tukey’s post hoc test.
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FoxO3a is phosphorylated in a PI3K-dependent manner and
trafficked out of the nucleus to the cytosol. At the same time,
SirT3 translocates from the nuclear compartment either to the
cytosol or themitochondrion in response to iron-triggered oxi-
dative stress.
Role of PI3K/Akt in Neuronal Survival—Because PI3K/Akt
was shown to be activated and, thus, involved in protecting
against cellular oxidants upon Fe2-induced oxidative stress,
we sought to determine whether activation of this pathway has
any involvement in neuronal survival. For this purpose, cells
were incubated in the presence of either Fe2 or its vehicle or
coincubated with 10 M LY294002 and Fe2, and morpholog-
ical changes, neuronal viability, and lipid peroxidation were
assessed. Photomicrographs show that the presence of PI3K
inhibitor together with Fe2 exacerbates morphological alter-
ations caused by Fe2 alone (Fig. 6A). Similarly,MTT reduction
showed that coincubation with LY294002 and Fe2 strongly
decreased neuronal survival compared with both the control
and the Fe2-treated conditions (Fig. 6B). Intriguingly, the
increase in lipid peroxidation levels observed during iron-in-
duced oxidative stress did not change in the presence of
LY294002 (Fig. 6C). To further investigate the role of Akt dur-
ing oxidative stress, cells were transfected with either Myr-Akt
(constitutively active mutant), the FoxO3a wild type (Foxo3a-
WT), the FoxO3a triple mutant (FoxO3a-TM, phosphoryla-
tion-deficient mutant), or the empty vector and then treated
with either Fe2 or its vehicle. Cellular oxidant levels were eval-
uated in these cells using the probe DCDCDHF. Fig. 6D shows
that there was no variation in neuronal oxidant levels under the
control conditions irrespective of the protein that was overex-
pressed. Fe2-exposure increased the production of cellular
oxidants in cells transfected with empty vectors. However,
overexpression of Myr-Akt decreased Fe2-induced oxidants
to the level of the control condition. Overexpression of
FoxO3a-WT did not alter oxidant levels generated by Fe2
itself, whereas overexpression of FoxO3a-TM significantly
increased the production of neuronal oxidants generated by
Fe2-exposure (Fig. 6D). As mentioned above, SOD1 and
SOD2, well known target genes of FOXO3a (24), decreased
upon iron-induced oxidative stress in our experimental model.
Therefore, we sought to determine whether PI3K inhibition
was able to restore the expression levels of these enzymes. Fig.
6E shows that the presence of LY294002 strongly increased
SOD1 and SOD2 expression. GSH levels did not show signifi-
FIGURE 5. FoxO3a trafficking.A, subcellular fractions of HT22 cells exposed to either Fe2 (25 and 50M) or its vehiclewere analyzed byWestern blot analysis
using antibodies against phospho-FoxO3a and FoxO3a. TheWesternblot analysis shown is representative of at least threedifferent experiments.B, subcellular
fractions of HT22 cells incubated in the presence of 10M LY294002 (or its vehicle) and then exposed to either Fe2 (25 and 50M) or its vehiclewere analyzed
byWestern blot analysis using antibodies against phospho-FoxO3a. One representative blot of three different experiments is shown. C, cells were grown onto
coverslips, incubated in the presence of 10M LY294002 (or its vehicle), exposed to either Fe2 (25 and 50M) or its vehicle, and processed for immunocyto-
chemistry using anti-Akt antibody. The picture shown is representative of three different experiments. D, cells were grown onto coverslips, exposed to either
Fe2 (25 and 50 M) or its vehicle, and then processed for immunocytochemistry using anti-FoxO3a antibody. TO-PRO was used as nuclear marker. One
representative picture of three different experiments is shown. E, lysates from cells exposed to either Fe2 or its vehicle were studied by Western blot assays.
The antibodies used were anti-SOD1, anti-SOD2, and anti-catalase. -actin was used as a loading control. Each blot is representative of at least three different
experiments. Bands of proteins were quantified using scanning densitometry. The data in the graph in the right panel represent the ratio between subcellular
protein expression and-actin, expressed as a percentage of the corresponding control condition (mean S.E. of three different experiments). ***, p 0.001
for each condition with respect to the control; Student’s t test. F, subcellular fractions of HT22 neurons exposed to either Fe2 (50 M) or its vehicle were
analyzed by Western blot analysis using anti-sirtuin 3 antibody. The Western blot analysis shown is representative of at least three different experiments.
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cant changes in the presence of iron with respect to the control.
However, the coincubation of iron with LY294002 strongly
diminished GSH levels (Fig. 6F). For an additional explanation
of this fact, we next examined the state of the -glutamylcys-
teine synthetase catalytic subunit (-GCSc), the rate-limiting
step enzyme forGSH synthesis. In the presence of iron, -GCSc
levels increased, and this rise in enzyme levels was abolished by
LY294002 (Fig. 6G). These results led us to conclude that the
FIGURE 6. Impact of PI3K inhibition on cell survival and ROS generation. A, HT22 cells were incubated in the presence of 10 M LY294002 (or its vehicle),
exposed to either Fe2 (50 M) or its vehicle for 24 h, and then observed by bright-field microscopy. Photomicrographs are representative of three to four
experiments. B, cells were treated as described in A, and cell viability was assessed by MTT reduction assay. The results are expressed as a percentage of the
control and representmean S.E. (n 3–4). ***, p 0.001with respect to the control; ##, p 0.01 as shown in the picture; one-way ANOVA and Tukey’s post
hoc test. C, cells were treated as described in A, and lipid peroxidationwas quantified by TBARS assay. Results are expressed as a percentage of the control and
representmean S.E. (n 3–4). ***, p 0.001with respect to the control; one-way ANOVA and Tukey’s post hoc test.D, HT22 neuronswere transfectedwith
either Myr-Akt (constitutively active mutant), FoxO3a-WT (the wild-type form of FoxO3a), FoxO3a-TM (non-phosphorylable mutant), or the empty vector and
exposed to Fe2 for 24 h. Then cellular oxidant levels were evaluated using 10 M DCDCDHF. Results (obtained by spectrofluorometry) are expressed as
arbitrary units and represent mean S.E. (n 3–4). aaa, p 0.001 Fe2-treated condition with respect to the same overexpressed protein in the absence of
the metal; ###, p 0.001 as shown in the picture; two-way ANOVA and Tukey’s post hoc test. E, lysates from cells treated as described in A were studied by
Western blot assays. The antibodies used were anti-SOD1 and anti-SOD2. -actin was used as a loading control. Each blot is representative of at least three
different experiments. Bands of proteins were quantified using scanning densitometry. The data in the graph in the right panel represent the ratio between
subcellular protein expression and -actin, expressed as a percentage of the corresponding control condition (mean S.E. of three different experiments). *,
p 0.05; **, p 0.01; and ***, p 0.001 for each condition with respect to the control; ###, p 0.001 shown in the picture; one-way ANOVA and Tukey’s post
hoc test. F, HT22 cells were treated as indicated in A, and GSH content was assessed. Results are expressed as pmol GSH/mg protein. **, p 0.01 with respect
to the control; ##, p 0.01 shown in the picture; one-way ANOVA and Tukey’s post hoc test. G, lysates from cells treated as described in A were analyzed by
Western blot analysis. The antibody used was anti--GCSc. -Actin was used as a loading control. Each blot is representative of at least three different
experiments. Bands of proteins were quantified as indicated in E. The data in the graph in the right panel represent the ratio between subcellular protein
expression and -actin, expressed as a percentage of the control (mean S.E. of three different experiments). *, p 0.05 with respect to the control; ###, p
0.001 shown in the picture; one-way ANOVA and Tukey’s post hoc test.
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PI3K/Akt pathway plays a key role in neuronal survival by pro-
tecting cells from ROS generation through GSH metabolism
regulation.
DISCUSSION
Oxidative stress has been considered as themain contributor
to neuronal synaptic dysfunction and loss inAD (25–27). In line
with this, compelling evidence has demonstrated that several
neurodegenerative disorders involving oxidative stress are
associatedwith an increase in brain Fe2 levels during the onset
and progression of the disease (28–31). Specifically, iron accu-
mulation has been shown in brain regions with clear signs of
neurodegeneration (32, 33). Recent studies have demonstrated
thatmolecules with the ability to bind iron are effective in slow-
ing disease progression in both AD models and patients.
Indeed, it has also been observed that this metal ion progres-
sively accumulates in the brain during normal aging (34). Over
the last decade, our laboratory has made considerable progress
in characterizing the effect of Fe2 in different neuronal mod-
els, from the synaptic ending to the entire retina (18–20,
35–39). The PI3K/Akt/GSK3 signaling pathway has been of
particular interest because it is involved in synaptic plasticity
and neuronal survival (19). In this study, we have moved to a
new neuronal model of Fe2-triggered mild oxidative stress.
Under these conditions (50 M Fe2), a pronounced loss of
synaptic endings, increased generation of cellular oxidants and
lipid peroxidation, but nomarked signs of neuronal death, were
observed. In addition, the PI3K/Akt pathway became activated
together with the concomitant inhibition of one of its down-
stream targets, GSK3. Our observations coincide with previ-
ous studies reporting that PI3K and its downstream effector
Akt are activated in response to oxidative stress in neurons. The
activation of this pathway in neurons subjected to oxidative
injury has been largely associated with neuronal survival
(40–42).
Our findings clearly illustrate that during Fe2-triggered
mild oxidative stress in hippocampal neurons, Akt accumulates
in the nucleus in a PI3K-dependent fashion and that this
nuclear compartmentation of Akt gives rise to FoxO3a phos-
phorylation (a phenomenon also shown to be dependent on
PI3K), inhibition, and nuclear exclusion. Of note, both Akt and
PI3K increase their nuclear localizationwithout involving cyto-
solic depletion, as would be expected. One possible explanation
is that an increased expression of these proteins could occur to
maintain their cytosolic concentration, thus counteracting
depletion as a consequence of nuclear translocation. In this
connection, similar patterns of subcellular distribution have
been shown by Boehme et al. (43), Nguyen et al. (44), Badve et
al. (45), andAhn et al. (46) forAkt and byDai et al. (47) for PI3K
regulatory (p85) and catalytic (p110) subunits, respectively.
Whether Akt-mediated phosphorylation of FoxO3a occurs in
the cytosol (after nuclear exclusion) or in the nucleus remains
to be clarified. In this regard, we consider that there is reason-
able evidence to indicate that Akt catalyzes FoxO3a phosphor-
ylation in the nucleus prior to transcription factor exclusion
(48, 49). If, on the other hand, FoxO3a was phosphorylated in
the cytosol, what would be the driving force thatmakes FoxO3a
translocate to the cytosol before being phosphorylated? And
why would Akt be trafficked to the nucleus after phosphory-
lating FoxO3a in the cytosol?
Here we present evidence of the existence of two pools of
Akt: cytosolic Akt, which is activated after oxidative insult and
then phosphorylates, thus inhibiting GSK3, and nuclear Akt
(encompassed by PI3K), which phosphorylates FoxO3a, inhib-
iting its transcriptional activity and promoting its nuclear exit.
Taken together, two prolife signals are displayed by the cell: the
inactivation of FoxO3a-dependent transcription and GSK3
nuclear exclusion (12, 24, 50–53).
Interestingly, Akt-dependent FoxO3a inactivation leads to a
decrease in SOD1 and SOD2 expression with no changes in
catalase expression, raising the question as to why it does so
because these antioxidant enzymes play an important role in
defeating oxidative stress. Previous reports from Linen et al.
(54) showed decreased SOD2 expression as a FoxO3a-depen-
dent event that rendered the experimental model more vulner-
able to oxidative stress. One possible explanation is that this is
the calculated risk involved in diminishing the FoxO3a-depen-
dent expression of prodeath genes such as FasL (a well docu-
mented target of FoxO3a). If this is so, it is logical to assume that
the neuron would adopt an alternative protective mechanism
against oxidative injury. The brain is known to generate large
amounts of ROS, and 2–4% of the oxygen consumed by the
mitochondria is diverted to produce superoxide (55). SOD con-
verts superoxide to hydrogen peroxide, which is subsequently
converted to water and O2 by glutathione peroxidase or cata-
lase (55). Alternatively, hydrogen peroxide can react with Fe2
through the Fenton reaction to generate hydroxyl radicals. Tak-
ing into account that the presence of Fe2would accelerate the
transformation of hydrogen peroxide to hydroxyl radicals, cat-
alase activity appears to be non-essential. In consequence, the
most appropriate candidate for clearing hydroxyl radicals
becomes GSH (56). Moreover, the increase in superoxide can
also be overcome non-enzymatically by the consumption of
GSH (57). In line with this, we demonstrate that -GCSc
expression increases in the presence of iron, which may be
responsible for the maintenance in the levels of GSH under
oxidative stress conditions, and that this preferential defeating
pathway is dependent on PI3K/Akt activation because its inhi-
bition strongly diminished not only GSH but also -GCSc
expression levels. In view of the results presented here, it can be
suggested that the activation of Akt during mild Fe2-induced
oxidative stress in hippocampal neurons mediates FoxO3a
inhibition with a consequent diminution in the expression of
death-related genes. In spite of the resultant SOD1 and SOD2
diminished expression, PI3K/Akt pathway governs the final
outcome by balancing GSH content.
In addition to phosphorylation, acetylation/deacetylation is
anothermechanism of regulation of FoxO transcription factors
upon oxidative stress (24). Our results suggest that the exit of
FoxO3a from the nucleus occurs via SirT3 export. The latter
may enhance the nuclear acetylated/deacetylated FoxO3a ratio,
therefore collaborating in the trafficking of this transcription
factor. Another possibility is that the exit of SirT3 from the
nucleus makes way for a FoxO3a-deacetylating enzyme in the
cytosol, thus promoting the return of the transcription factor to
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the nuclear compartment. Further studies are required to clar-
ify this issue.
Although generally known to play a key role in metabolism
and in survival responses to numerous stimuli, the activated
PI3K/Akt pathway has also been reported to promote cell death
or play a prodeath role (15, 58). In seeking to resolve this ambi-
guity, we used different approaches to demonstrate the protec-
tive role that the PI3K/Akt pathway exerts in preventing the
increase of cellular oxidants in our experimental model. The
overexpression of Akt (constitutively active mutant) was suffi-
cient to prevent the increase in ROS levels generated by Fe2
exposure. However, this role cannot be attributed to a specific
subcellular localization of Akt because myristolation of its N
terminus facilitates activation by promoting the association of
Myr-Akt with the plasma membrane, which may reduce
nuclear translocation and retainmore activity in themembrane
cytoplasmic compartments but does not unequivocally dismiss
the possibility of nuclear localization (59). On the other hand,
when Akt-mediated phosphorylation of FoxO3a is abolished
(FoxO3a-TM), ROS generation increased significantly. All
these findings clearly illustrate that Akt has a nuclear protective
rolewith FoxO3a as a key target (60).Our results do not rule out
the possibility of an important additional cytosolic role of Akt.
More in-depth studieswould be required to resolve this. Unrav-
eling the target genes that are up/down-regulated as a result of
Akt-mediated FoxO3a inactivation as well as the antioxidant
system used mainly by the neuron will provide important tools
for future therapeutic treatment of oxidative stress-related
diseases.
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